4.7 Article

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Myeloid-derived suppressor cell heterogeneity and subset definition

Elisa Peranzoni et al.

CURRENT OPINION IN IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Functional analysis of monocyte MHC class II compartments

Allyson Bunbury et al.

FASEB JOURNAL (2009)

Article Immunology

IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients

Susanna Mandruzzato et al.

JOURNAL OF IMMUNOLOGY (2009)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Immunology

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

Ilaria Marigo et al.

IMMUNOLOGICAL REVIEWS (2008)

Article Oncology

Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden

Massimo Cristofanilli et al.

CLINICAL BREAST CANCER (2007)

Article Medicine, Research & Experimental

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

Giovanna Gallina et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Oncology

Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer

M Cristofanilli et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, Research & Experimental

Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3

G de Saint Basile et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Oncology

Down-regulation of the CD3-ζ chain in sentinel node biopsies from breast cancer patients

J Schüle et al.

BREAST CANCER RESEARCH AND TREATMENT (2002)

Article Immunology

PD-L2 is a second ligand for PD-I and inhibits T cell activation

Y Latchman et al.

NATURE IMMUNOLOGY (2001)